New Cousteau-Linked...
Health Care: Drugs
ADVENTRX Pharmaceuticals Inc. (ANX: AMEX)
$0.51 -0.01 | -2.11%
06/04/12 - 03:14 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 43.57M | 27.98M | 8.67M | 9.85M |
| Receivables | 17.24K | 1.98K | 14.84K | 121.74K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 815.01K | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 51.79M | 28.41M | 8.97M | 10.45M |
| Property, Plant & Equipment, Gross | 738.65K | 299.27K | 382.90K | 823.56K |
| Accumulated Depreciation & Depletion | 274.19K | 255.02K | 338.69K | 624.51K |
| Property, Plant & Equipment, Net | 464.46K | 44.25K | 44.21K | 199.05K |
| Intangibles | 6.55M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 43.91K | 33.48K | 10.51K | 60.66K |
| Total Non-Current Assets | 10.06M | 77.74K | 54.72K | 259.72K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 61.86M | 28.49M | 9.03M | 10.71M |
| Accounts Payable | 451.70K | 479.78K | 385.36K | 1.72M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 140.12K | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 2.47M | 1.80M | 2.35M | 4.71M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 2.61M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.61M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.08M | 1.80M | 2.35M | 4.71M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 56.78M | 26.69M | 6.67M | 6.00M |
| Common Par | 47.72K | 15.48K | 205.29K | 90.25K |
| Additional Paid In Capital | 226.12M | 182.80M | 148.51M | 131.75M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -169.39M | -156.13M | -142.04M | -125.85M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -2.30K | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 56.78M | 26.69M | 6.67M | 6.00M |
| Total Equity | 56.78M | 26.69M | 6.67M | 6.00M |
| Total Liabilities & Stock Equity | 61.86M | 28.49M | 9.03M | 10.71M |
| Total Common Shares Outstanding | 47.72M | 15.48M | 8.21M | 3.61M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 28.18M | 13.18M | 4.67M | 3.61M |
| Diluted Weighted Shares Outstanding | 28.18M | 13.18M | 4.67M | 3.61M |
| Number of Employees | 13 | 3 | 3 | 14 |
| Number of Part-Time Employees | 1 | 1 | 1 | 0 |
Portfolios with ANX
- Portfolio NameUser Type
- Uservlady 1
- Usertesting
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Trades for Seco...
- UserDusty's Tracker
- UserDustel's Growth Stocks
- UserOwn
- UserASCO 2010 Part 2
- UserCDBrevard Portfolio 1
Latest ANX Headlines from TheStreet
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 11.11.11 | 08:11 am
- 5 Stocks Under $10 Setting Up to Trade Higher 09.15.11 | 01:09 pm
- 5 Stocks Setting Up to Break Out 09.09.11 | 03:09 pm
- ADVENTRX Stock Hits New 52-Week Low (ANX) 08.10.11 | 09:08 am
- Adventrx: FDA Rejects Lung Cancer Drug 08.10.11 | 07:08 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Sangamo Biosciences 07.22.11 | 05:07 am
- Biotech Stock Live Chat 07.15.11 | 12:07 pm
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
Press Releases for ANX
- ADVENTRX Pharmaceuticals To Sponsor & Present At The Martin Center's 2012 Sickle Cell Disease Conference - PR Newswire 04.16.12 | 08:04 am
- ADVENTRX Announces Establishment Of Regulatory Advisory Board - PR Newswire 04.09.12 | 08:04 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 03.21.12 | 09:03 am
- ADVENTRX CEO Selected By Combined Health Agencies As A 2012 Health Hero - PR Newswire 03.15.12 | 08:03 am
- ADVENTRX Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 14 - PR Newswire 02.07.12 | 08:02 am
- Vista Partners Publishes February 2012 Newsletter - PR Newswire 02.02.12 | 09:02 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 12.15.11 | 09:12 am
- ADVENTRX Meets With FDA To Discuss Development Plans For ANX-188 - PR Newswire 12.01.11 | 08:12 am
- ADVENTRX Announces Closing Of Public Offering - PR Newswire 11.16.11 | 03:11 pm
- ADVENTRX Prices Public Offering Of Stock - PR Newswire 11.11.11 | 08:11 am
Partner Headlines for ANX
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 12.19.11 | 09:12 am
- Why CytRx Corporation Is Still A Big Biotech 'If' Play - Seeking Alpha 12.14.11 | 09:12 am
- Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets - NASDAQ 12.07.11 | 06:12 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 12.02.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Company News for August 11, 2011 - Corporate Summary - Zacks 08.11.11 | 10:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.21.11 | 09:07 am
- Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential - Seeking Alpha 07.21.11 | 08:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
